Premium
Chromatic sensitivity in subjects with diabetes
Author(s) -
O'NEILLBIBA M,
RODRIGUEZCARMONA M,
RAUSCHER F,
BARBUR J,
SIVAPRASAD S
Publication year - 2009
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2009.3124.x
Subject(s) - mesopic vision , medicine , photopic vision , diabetic retinopathy , microperimetry , ophthalmology , chromatic scale , retinopathy , diabetes mellitus , audiology , visual acuity , optometry , retinal , optics , physics , endocrinology
Purpose Diabetic retinopathy is a major cause of blindness in the Western World and remains one of the most serious complications of diabetes mellitus. The gold standard to measure functional change in diabetic (DB) patients is LogMAR or Snellen VA. The aim of this study was to measure and characterise the severity of visual function loss in subjects with DB using sensitive psychophysical tests and to quantify accurately how changes in management of the disease correlate with changes in visual function. Methods Three groups of patients (n=50) were included in this study:DB patients with and without retinopathy and patients with no DB. Each patient had a full ophthalmic examination prior to psychophysical assessment. Colour vision assessment was carried out using the CAD test (Colour Assessment & Diagnosis) that provides a measure of both yellow‐blue and red‐green loss of chromatic sensitivity (CS). Rapid flicker (RF) was also measured by assessing sensitivity to a 20Hz flicker stimulus at five locations in the central visual field (fovea and 1.5 degrees from fixation in each quadrant). All tests were carried out at photopic and high mesopic light. Results The results show significant loss of CS (p <.001) and some loss in RF sensitivity (p <.01). The most sensitive measure of visual loss was CS.There was also a positive correlation between CAD thresholds as a measure of CS and improved DB control. Conclusion The results suggest that loss of visual function precedes structural changes in the retina and could be used as a means of detecting early structural changes in the retina that precede clinical diagnosis of retinopathy. Preliminary results also suggest that changes in CAD thresholds provide an objective way of monitoring the progress of DB and/or treatment outcome.